Author Correction: Calcium channel blocker amlodipine besylate therapy is associated with reduced case fatality rate of COVID-19 patients with hypertension.

Lei-Ke Zhang Yuan Sun Haolong Zeng Qingxing Wang Xiaming Jiang Wei-Juan Shang Yan Wu Shufen Li Yu-Lan Zhang Zhao-Nian Hao Hongbo Chen Runming Jin Wei Liu Hao Li Ke Peng Gengfu Xiao

Cell Discov

State Key Laboratory of Virology, Wuhan Institute of Virology, Center for Biosafety Mega-Science, Chinese Academy of Sciences, Wuhan, Hubei, 430071, China.

Published: May 2021

A Correction to this paper has been published: https://doi.org/10.1038/s41421-021-00267-0.

Download full-text PDF	Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8093281	PMC
http://dx.doi.org/10.1038/s41421-021-00267-0	DOI Listing

Publication Analysis

Top Keywords

author correction

correction calcium

calcium channel

channel blocker

blocker amlodipine

amlodipine besylate

besylate therapy

therapy associated

associated reduced

reduced case

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!